Biotechnology Stocks
| # | Últimos 7 dias | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| 4404 |  MCRB Seres Therapeutics, Inc. - Common Stock | 2.63 USD | -3.31% | -11.74% | -52.53% | -68.04% | 26.15 M USD | ||
| 4406 |  ABVC ABVC BioPharma, Inc. - Common Stock | 0.98 USD | -2.00% | -4.85% | +6.52% | -69.94% | 26.12 M USD | ||
| 4408 |  ATYR aTyr Pharma, Inc. - Common Stock | 0.26 USD | -7.14% | -10.34% | -45.83% | -73.20% | 25.50 M USD | ||
| 4410 |  EVAX Evaxion A/S - American Depositary Share | 3.05 USD | -2.87% | -5.57% | -5.28% | -8.13% | 25.44 M USD | ||
| 4415 |  BYSI BeyondSpring, Inc. - Ordinary Shares | 0.61 USD | -4.69% | -26.51% | 0.00% | -66.67% | 25.08 M USD | ||
| 4432 |  ATOS Atossa Therapeutics, Inc. - Common Stock | 2.42 USD | -1.63% | +8.52% | +2.54% | +106.84% | 24.15 M USD | ||
| 4433 |  KYNB Kyntra Bio, Inc. - Common Stock | 5.96 USD | -1.32% | -9.70% | -26.60% | -37.33% | 24.13 M USD | ||
| 4474 |  COCP Cocrystal Pharma, Inc. - Common Stock | 1.07 USD | 0.00% | -8.55% | -15.08% | -13.71% | 20.61 M USD | ||
| 4503 |  JSPR Jasper Therapeutics, Inc. - Class A Common Stock | 0.56 USD | -1.75% | -6.67% | -18.84% | -77.60% | 18.63 M USD | ||
| 4504 |  ESLA Estrella Immunopharma, Inc. - Common Stock | 0.42 USD | 0.00% | -8.70% | -32.26% | -66.40% | 18.27 M USD | ||
| 4509 |  NEUP Neuphoria Therapeutics Inc. - Common Stock | 3.35 USD | -2.05% | -6.69% | -11.84% | -81.79% | 18.13 M USD | ||
| 4528 |  GNTA Genenta Science S.p.A. - American Depositary Shares | 0.71 USD | -6.58% | -13.41% | -23.66% | -78.81% | 16.64 M USD | ||
| 4532 |  AKTX Akari Therapeutics Plc - American Depositary Shares | 8.49 USD | -1.62% | -5.77% | -20.13% | +793.68% | 16.53 M USD | ||
| 4538 |  ACTU Actuate Therapeutics, Inc. - Common stock | 0.68 USD | -5.56% | -26.88% | -50.72% | -83.33% | 16.33 M USD | ||
| 4541 |  BCDA BioCardia, Inc. - Common Stock | 1.06 USD | -2.75% | +1.92% | -4.50% | -8.62% | 16.05 M USD | ||
| 4543 |  PTN Palatin Technologies, Inc. Common Stock | 9.01 USD | -5.36% | +3.56% | -26.63% | +24.28% | 16.05 M USD | ||
| 4544 |  DYAI Dyadic International, Inc. - Common Stock | 0.44 USD | -4.35% | -4.35% | -13.73% | -61.06% | 16.03 M USD | ||
| 4546 |  LPCN Lipocine Inc. - Common Stock | 1.93 USD | -12.27% | -8.53% | -16.81% | -33.45% | 15.91 M USD | ||
| 4548 |  MRKR Marker Therapeutics, Inc. - Common Stock | 0.95 USD | -8.65% | -10.38% | -21.49% | -10.38% | 15.84 M USD | ||
| 4554 |  ALLR Allarity Therapeutics, Inc. - Common stock | 0.98 USD | 0.00% | -7.55% | -24.03% | -44.32% | 15.59 M USD |
Notícias Biotechnology Stocks
Estudo da Lancet mostra alívio mais rápido com remédio da Pharvaris para AEH
Raymond James inicia cobertura da Kymera Therapeutics com recomendação acima da média
Raymond James inicia cobertura da Nektar com classificação de desempenho de mercado
Ação da Palisade Bio inicia cobertura com Outperform na Raymond James
Raymond James mantém recomendação para ações da Liquidia em meio a processos judiciais
Ginkgo Bioworks vai apoiar o programa NSF X-Labs com acesso a laboratório
AbCellera apresentará dados de fase 1/2 sobre candidato a medicamento para menopausa
Gainers Biotechnology Stocks
 GRDX GridAI Technologies Corp. - Common Stock | 4.80 | +16.50% |
 CLGN CollPlant Biotechnologies Ltd. - Ordinary Shares | 3.97 | +14.74% |
 IPSC Century Therapeutics, Inc. - Common Stock | 1.46 | +14.06% |
 ADCT ADC Therapeutics SA Common Shares | 1.59 | +11.97% |
 CDTTW CDT Equity Inc. - Warrant | 0.0117 | +11.43% |
 SRZN Surrozen, Inc. - Common Stock | 27.97 | +11.26% |
 ANL Adlai Nortye Ltd - American Depositary Shares | 15.51 | +10.39% |
 QNCX Quince Therapeutics, Inc. - Common Stock | 29.36 | +9.88% |
Losers Biotechnology Stocks
 SABSW SAB Biotherapeutics, Inc. - Warrant | 0.0088 | -27.87% |
 YDESW YD Bio Limited - Warrants | 0.5000 | -23.08% |
 CRBU Caribou Biosciences, Inc. - Common Stock | 0.48 | -22.58% |
 TCRX TScan Therapeutics, Inc. - Common Stock | 0.23 | -17.86% |
 KALA KALA BIO, Inc. - Common Stock | 0.30 | -16.67% |
 BRTX BioRestorative Therapies, Inc. - Common Stock | 1.89 | -15.62% |
 MLEC Moolec Science SA - Ordinary Shares | 4.19 | -12.89% |
LPCN Lipocine Inc. - Common Stock | 1.93 | -12.27% |